Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Benisvy

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
World Journal of Surgical Oncology|October 30, 2025
Loss of neuromonitoring signal in thyroid surgery: predictive factors and surgical strategiesJérôme Houdu, Alexandre Bozec, Renaud Schiappa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 21, 2017
Iodinated Contrast Agents Perturb Iodide Uptake by the Thyroid Independently of Free IodideGeorges Vassaux, Colette Zwarthoed, Laurie Signetti, et al.
European Journal of Endocrinology|January 17, 2016
Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled studyDavid Taïeb, Claire Bournaud, Marie-Claude Eberle, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 25, 2011
Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 casesAlexandre Bozec, Olivier Dassonville, Emmanuel Chamorey, et al.
The Lancet. Diabetes & Endocrinology|May 30, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trialMartin Schlumberger, Sophie Leboulleux, Bogdan Catargi, et al.
The New England Journal of Medicine|May 4, 2012
Strategies of radioiodine ablation in patients with low-risk thyroid cancerMartin Schlumberger, Bogdan Catargi, Isabelle Borget, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2021
Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYRChristelle de la Fouchardière, Yann Godbert, Cécile Dalban, et al.
Thyroid : Official Journal of the American Thyroid Association|August 15, 2018
Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid CancerFrancoise Borson-Chazot, Emmanuelle Dantony, Frederic Illouz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid CancerSophie Leboulleux, Christine Do Cao, Slimane Zerdoud, et al.
The New England Journal of Medicine|March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid CancerSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
World Journal of Surgical Oncology|October 30, 2025
Loss of neuromonitoring signal in thyroid surgery: predictive factors and surgical strategiesJérôme Houdu, Alexandre Bozec, Renaud Schiappa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 21, 2017
Iodinated Contrast Agents Perturb Iodide Uptake by the Thyroid Independently of Free IodideGeorges Vassaux, Colette Zwarthoed, Laurie Signetti, et al.
European Journal of Endocrinology|January 17, 2016
Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled studyDavid Taïeb, Claire Bournaud, Marie-Claude Eberle, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 25, 2011
Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 casesAlexandre Bozec, Olivier Dassonville, Emmanuel Chamorey, et al.
The Lancet. Diabetes & Endocrinology|May 30, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trialMartin Schlumberger, Sophie Leboulleux, Bogdan Catargi, et al.
The New England Journal of Medicine|May 4, 2012
Strategies of radioiodine ablation in patients with low-risk thyroid cancerMartin Schlumberger, Bogdan Catargi, Isabelle Borget, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2021
Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYRChristelle de la Fouchardière, Yann Godbert, Cécile Dalban, et al.
Thyroid : Official Journal of the American Thyroid Association|August 15, 2018
Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid CancerFrancoise Borson-Chazot, Emmanuelle Dantony, Frederic Illouz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid CancerSophie Leboulleux, Christine Do Cao, Slimane Zerdoud, et al.
The New England Journal of Medicine|March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid CancerSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
Pageof 3